BORA PHARMACEUTICAL LABORATORIES IN

Type: Manufacturer (specifically, a Contract Development and Manufacturing Organization - CDMO)

Company Introduction:

BORA PHARMACEUTICAL LABORATORIES INC. is a leading Contract Development and Manufacturing Organization (CDMO) based in Taiwan. It operates as a manufacturer, providing comprehensive services for the pharmaceutical industry.

BORA specializes in the development, manufacturing, and packaging of a wide range of pharmaceutical products, including oral solid dosages (tablets, capsules), liquids, and semi-solids. The company is recognized for its commitment to global quality standards and regulatory compliance, holding certifications from major regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) GMP, Japan Pharmaceuticals and Medical Devices Agency (PMDA), and others.

With a strong focus on advanced technology, robust quality systems, and extensive expertise, BORA serves a global clientele, offering integrated solutions from early-stage development to commercial production. It is a key player in the Asian pharmaceutical manufacturing landscape, known for its reliability and high-quality output.

Bora Pharmaceutical Laboratories Inc. Product Portfolio

Ophthalmology

- Pred Forte (Prednisolone Acetate Ophthalmic Suspension)

- Econopred Plus (Prednisolone Acetate Ophthalmic Suspension)

- Flarex (Fluorometholone Acetate Ophthalmic Suspension)

- Betoptic S (Betaxolol Hydrochloride Ophthalmic Suspension)

- Azopt (Brinzolamide Ophthalmic Suspension)

- Travatan (Travoprost Ophthalmic Solution)

Dermatology

- Luxiq (Betamethasone Valerate Foam)

- Olux (Clobetasol Propionate Foam)

- Evoclin (Clindamycin Phosphate Foam)

Neurology and Psychiatry

- Keppra (Levetiracetam)

- Remeron (Mirtazapine)

Gastroenterology

- Dexilant (Dexlansoprazole)

Other Therapeutic Areas

- Various oral solid dosage forms including tablets and capsules for chronic disease management

- Contract Development and Manufacturing Organization (CDMO) services for global pharmaceutical partners involving complex formulations and specialized dosage forms